Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-09 2:49 pm Sale | 2026-10-01 | 13G | PYXIS ONCOLOGY INC PYXS | GordonMD Global Investments LP | 20,441,948 16.400% | -7,546,766 (-26.96%) | Filing History |
| 2026-10-05 10:25 am Purchase | 2026-10-01 | 13G | PYXIS ONCOLOGY INC PYXS | Coastlands Capital LP | 6,448,907 5.420% | 6,448,907 (New Position) | Filing History |
| 2026-10-02 08:34 am Purchase | 2026-10-01 | 13G | PYXIS ONCOLOGY INC PYXS | GordonMD Global Investments LP | 27,988,714 17.500% | 17,963,805 (+179.19%) | Filing History |
| 2026-07-10 4:07 pm Purchase | 2026-07-02 | 13G | PYXIS ONCOLOGY INC PYXS | BIOTECHNOLOGY VALUE FUND L P | 8,336,902 9.990% | 8,336,902 (New Position) | Filing History |
| 2026-07-02 4:10 pm Purchase | 2026-06-30 | 13G | PYXIS ONCOLOGY INC PYXS | GordonMD Global Investments LP | 10,024,909 12.100% | 6,190,169 (+161.42%) | Filing History |
| 2026-02-09 11:23 am Purchase | 2025-12-31 | 13G | PYXIS ONCOLOGY INC PYXS | Laurion Capital Management LP | 4,796,479 7.720% | 1,170,505 (+32.28%) | Filing History |
| 2025-10-14 4:05 pm Sale | 2025-09-30 | 13G | PYXIS ONCOLOGY INC PYXS | Millennium Management LLC | 818,134 1.300% | -2,724,529 (-76.91%) | Filing History |
| 2025-09-23 2:02 pm Purchase | 2025-07-14 | 13G | PYXIS ONCOLOGY INC PYXS | GordonMD Global Investments LP | 3,834,740 6.200% | 3,834,740 (New Position) | Filing History |
| 2025-07-17 8:12 pm Sale | 2025-06-30 | 13G | PYXIS ONCOLOGY INC PYXS | BlackRock, Inc. BLK | 926,805 1.500% | -2,417,336 (-72.29%) | Filing History |
| 2025-07-01 4:37 pm Purchase | 2025-06-27 | 13G | PYXIS ONCOLOGY INC PYXS | Millennium Management LLC | 3,542,663 5.700% | 3,542,663 (New Position) | Filing History |
| 2025-05-06 4:17 pm Sale | 2025-03-31 | 13G | PYXIS ONCOLOGY INC PYXS | Integrated Core Strategies (US) LLC | 2,488,079 4.000% | -672,060 (-21.27%) | Filing History |
| 2025-04-02 9:25 pm Purchase | 2025-03-31 | 13D | PYXIS ONCOLOGY INC PYXS | Lara Sullivan, M.D. | 7,543,007 11.210% | 918,308 (+13.86%) | Filing History |
| 2025-02-14 4:01 pm Sale | 2024-12-31 | 13G | PYXIS ONCOLOGY INC PYXS | Ridgeback Capital Investments L.P. | 359,231 0.600% | -3,985,997 (-91.73%) | Filing History |
| 2025-02-14 08:48 am Sale | 2024-12-31 | 13G | PYXIS ONCOLOGY INC PYXS | Deep Track Capital, LP | 0 0.000% | -4,184,100 (Position Closed) | Filing History |
| 2025-02-04 3:45 pm Purchase | 2024-12-31 | 13G | PYXIS ONCOLOGY INC PYXS | BlackRock, Inc. BLK | 3,344,141 5.600% | 3,344,141 (New Position) | Filing History |
| 2024-12-23 6:31 pm Purchase | 2024-12-23 | 13D | PYXIS ONCOLOGY INC PYXS | Lara Sullivan, M.D. | 6,624,699 10.300% | 1,135,000 (+20.68%) | Filing History |
| 2024-12-16 4:04 pm Purchase | 2024-12-09 | 13G | PYXIS ONCOLOGY INC PYXS | Integrated Core Strategies (US) LLC | 3,160,139 5.300% | 3,160,139 (New Position) | Filing History |
| 2024-11-12 11:53 am Purchase | 2024-09-30 | 13G | PYXIS ONCOLOGY INC PYXS | Laurion Capital Management LP | 3,625,974 6.150% | 455,171 (+14.36%) | Filing History |
| 2024-11-06 4:36 pm Unchanged | 2024-09-30 | 13G | PYXIS ONCOLOGY INC PYXS | Bayer World Investments B.V. | 2,742,338 4.700% | 0 (Unchanged) | Filing History |
| 2024-04-03 5:10 pm Purchase | 2024-03-26 | 13D | PYXIS ONCOLOGY INC PYXS | Lara Sullivan, M.D. | 5,489,699 8.890% | 1,319,425 (+31.64%) | Filing History |